(Q37208506)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

review article

1 reference

title

How have outcomes for patients with follicular lymphoma changed with the addition of monoclonal antibodies? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

author name string

Clara Chan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

language of work or name

1 reference

1 July 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

1263-1273

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

An update of the epidemiology of non-Hodgkin's lymphoma

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Follicular lymphoma: time for a re-think?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Follicular lymphoma international prognostic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Antibody-induced intracellular signaling works in combination with radiation to eradicate lymphoma in radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

131I-tositumomab therapy as initial treatment for follicular lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Phase II trial of CHOP chemotherapy followed by tositumomab/iodine I-131 tositumomab for previously untreated follicular non-Hodgkin's lymphoma: five-year follow-up of Southwest Oncology Group Protocol S9911.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Abbreviated chemotherapy with fludarabine followed by tositumomab and iodine I 131 tositumomab for untreated follicular lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Prolonged treatment with rituximab in patients with follicular lymphoma significantly increases event-free survival and response duration compared with the standard weekly x 4 schedule.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

Rituximab Added to First-Line Mitoxantrone, Chlorambucil, and Prednisolone Chemotherapy Followed by Interferon Maintenance Prolongs Survival in Patients With Advanced Follicular Lymphoma: An East German Study Group Hematology and Oncology Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190802090805

10.1080/10428190802090805

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18604715%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference